SCHEMBL4726486

SCHEMBL4726486

CCn1c2c(c3cc(-c4ccccc4)ccc31)CCCC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.52
RAB9A P51151 1/20 0.52
PTGDR2 Q9Y5Y4 2/20 0.48
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
HSD17B10 Q99714 2/20 0.47
MEN1 O00255 1/20 0.47
GLA P06280 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
KMT2A Q03164 1/20 0.47
RORC P51449 3/20 0.45
ALDH1A1 P00352 1/20 0.45
BCHE P06276 2/20 0.43
HTR6 P50406 3/20 0.43
CHRM2 P08172 1/20 0.43
HTR1A P08908 1/20 0.43
CHRM5 P08912 1/20 0.43
ADRA2A P08913 1/20 0.43
DRD2 P14416 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1459437 0.81 CA1 (0.71) KDM4ERAB9ACA1CA2HSD17B10
SCHEMBL30184445 0.81 CA1 (0.71) KDM4ERAB9ACA1CA2HSD17B10
SCHEMBL19271274 0.80 HSD17B10 (0.64) KDM4ERAB9AHSD17B10MEN1KMT2A
SCHEMBL14157802 0.79 CA1 (0.71) KDM4ERAB9ACA1CA2HSD17B10
SCHEMBL13877234 0.79 PTGDR2 (0.46) KDM4ERAB9APTGDR2MEN1KMT2A
SCHEMBL3362461 0.78 TSPO (0.55) KDM4EHSD17B10MEN1KMT2AALDH1A1
SCHEMBL15899412 0.78 HTR6 (0.57) KDM4ERAB9ACA1CA2HSD17B10
SCHEMBL13877230 0.78 BCHE (0.55) KDM4ERAB9APTGDR2HSD17B10RORC
SCHEMBL4727325 0.78 MAPT (0.59) KDM4ERAB9ACA1CA2HSD17B10
SCHEMBL19271276 0.78 KDM4E (0.52) KDM4ERAB9ACA1CA2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021745-A2 HEPATITIS C VIRUS ENTRY INHIBITORS ITHERX PHARMACEUTICALS, INC. (US) 2008-02-21 WO disclosed